摘要
运用DEA-Malmquist指数法测算2000—2010年中国医药制造业研发效率,并分析其变化趋势。研究结果表明,中国医药制造业研发效率总体呈增长趋势,其增长的主要动力源于技术效率的改善;医药制造业研发效率区域差异显著,主要原因在于技术进步与技术效率不能协同增长;从变化趋势看,中国东部省份医药制造业研发效率收敛趋势明显,但全国尚未形成医药制造业研发效率的收敛趋势。
This paper uses the DEA-Malmquist Index to measure China＇s pharmaceutical manufacturing R ＆ D effi- ciency from 2000 to 2010, and ana]yze the convergence trend. The results indicate that China＇s overall pharmaceuti- cal manufacturing R＆D efficiency is on an uphill trend, the main driver of growth in R＆D efficiency stems from tech- nical efficiency; R＆D regional efficiency differs significantly, the main reason being that technological progress and technical efficiency cannot synchronize with growth. Except for the eastern region, central and western regions as well as the national R＆D efficiency convergence trend has not yet formed, technology diffusion effect cannot form the main reason for the R＆D efficiency unrealized convergence.
出处
《北京航空航天大学学报（社会科学版）》
2013年第6期69-73,共5页
Journal of Beijing University of Aeronautics and Astronautics：Social Sciences edition Edition
基金
教育部人文社会科学研究规划青年基金资助项目(12YJC790301)
福建师范大学青年科研骨干教师基金资助项目(fjsdjk2012008)
作者简介
作者简介：邹文杰（1975-），男，福建古田人，副教授，博士，研究方向为技术创新与产业发展
